<DOC>
	<DOCNO>NCT00969956</DOCNO>
	<brief_summary>Diabetes cause serious complication well know . In study aim follow 950 patient diabetes 15 year study , diabetes complication occurs .</brief_summary>
	<brief_title>Time To Complications Occurs Diabetes</brief_title>
	<detailed_description>Background : That diabetes cause serious diabetic complication eye , kidney , nerve large vessel know . Good metabolic control first 8-10 year show delay even alleviate diabetes complication , entirely prevent . When complication occur early diabetes onset also likely genetic cause . If various diabetes complication different formation mechanism different sensitivity blood sugar impact study previously . Hypothesis : 1 . Genetic factor determine increase risk early onset complication . 2 . Oxidative stress increase risk complication . 3 . Inflammation , hyperlipidemia hypertension lead hypoxia oxidative stress . 4 . Combined hypoxia hyperglycemia lead complication . Questionnaires : 1 . Are measurable risk factor indicate different sensitivity develop diabetes complication ? 2 . Are differences men woman ? 3 . Are differences type 1 type 2 diabetes ? Knowledge achievement : Being able anticipate prevent diabetes complication specific approach would mean major benefit patient society . Inclusions criterion : Diabetes type 1 , 2 LADA : 18-75 year age . Group A : 150 Type 1 Diabetes , duration 15 year ( +/- 2 year ) 150 Type 2 Diabetes 2 year ( +/- 2 year ) ( 50 % K / M ) Group B : 150 Type 1 Diabetes , duration 20 year ( +/- 2 year ) 150 Type 2 Diabetes 7 year ( +/- 2 year ) ( 50 % K / M ) Group C : 150 Type 1 Diabetes , duration 25 year ( +/- 2 year ) 150 Type 2 Diabetes 12 year ( +/- 2 year ) ( 50 % K / M ) Group D : 50 LADA , onset 35 year age , duration 5-10 year ( 50 % K / M ) Follow-up visit : Group A : After 3 , 8 13 year Group B : After 5 , 10 15 year Group C : After 5 , 10 15 year Group D : After 3 , 8 13 year Definitions : Type 1 Diabetes : Positive ICA-antibodies and/or GAD-antibodies and/or neg C-peptide . Debut &lt; 30 year age . Type 2 Diabetes : Negative ICA-antibodies GAD-antibodies pos C-peptide ( &gt; 0.35 mmol/l ) . LADA : Positive ICA-antibodies and/or GAD-antibodies . Debut &gt; 35 year age . Retinopathy : Level retinopathy base fundus photography judge experienced ophthalmologist classify accord DRP classification five step : 1 . No retinopathy , 2 . Mild non-proliferative retinopathy , 3 . Moderate non-proliferative retinopathy , 4 . Severe non-proliferative retinopathy , 5 . Proliferative retinopathy ESRD ( end stage renal disease ) : Dialysis transplantation demanding , GFR ( glomerular filtration rate ) &lt; 10 ml/min . Overt nephropathy : Albumin excretion least two consecutive measurement , ≥ 300 mg/L and/or S-Creatinine &gt; 100 woman &gt; 110 mmol/l men . Incipient nephropathy : Albuminuria 30 - 300mg/L Urine albumin/Creatinine &gt; 3 . Hypertension : Measured blood pressure sit position 10 minute rest , least two consecutive measurement least 4 week , ≥ 130/80 . Hyperlipidemia : ApoA-1/ApoB : &gt; 0.5 and/or Triglycerides &gt; 1,7 mmol/L and/or LDL &gt; 2.5 mmol/L and/or HDL woman &lt; 1.3 , men &lt; 1.1 mmol/L and/or cholesterol &gt; 4.5 mmol/L . Heart disease : History myocardial infarction , angina pectoris and/or ischemic heart disease ( file note ) . Pharmacological treatment ischemic heart disease , heart failure pathological electrocardiographic change accord Minnesota code . Cerebrovascular disease : Deemed : recorded patient file and/or pathological finding demonstrate CT/MR . Peripheral vascular disease : Ankle Index &lt; 0.9 ( blood pressure arm &gt; ankle ) Clinical macroangiopathy , ( absence peripheral pulse ) history typical claudication intermittens . Neuropathy : Foot investigation : According international consensus investigation risk assessment diabetic foot view peripheral autonomic neuropathy ( PAN ) peripheral sensory neuropathy ( PSN ) .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Diabetes type 1 , 2 LADA : 1875 year age . Group A : 150 Type 1 Diabetes , duration 15 year ( +/2 year ) 150 Type 2 Diabetes 2 year ( +/2 year ) ( 50 % F/M ) Group B : 150 Type 1 Diabetes , duration 20 year ( +/2 year ) 150 Type 2 Diabetes 7 year ( +/2 year ) ( 50 % F/M ) Group C : 150 Type 1 Diabetes , duration 25 year ( +/2 year ) 150 Type 2 Diabetes 12 year ( +/2 year ) ( 50 % F/M ) Group D : 50 LADA , onset 35 year age , duration 510 year ( 50 % F/M ) Type 1 Diabetes : Positive ICA antibodies and/or GADantibodies and/or neg Cpeptide . Debut &lt; 30 year age . Type 2 Diabetes : Negative ICAantibodies GADantibodies pos Cpeptide ( &gt; 0.35 mmol/l ) . LADA : Positive ICAantibodies and/or GADantibodies . Debut &gt; 35 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Diabetes , Complication , Cardio-vascular disease</keyword>
</DOC>